Vanucizumab

A4DAB288 | Phase-II
ANGPT2;VEGFA
G1;G1 / None
Roche
Phase-II
Bispecific mAb
RG-7221 RG7221 RG 7221 RO-5520985 RO5520985 RO 5520985
—
Avg A4D Score
-0.6882
Score Range
-0.75 to -0.64
Structures
12
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB288_6bft_H_L 6bft 98% -0.7047 6.5 4.0 -0.3845 -0.7469
A4DAB288_1bj1_H_L 1bj1 100% -0.6886 6.5 4.0 -0.1696 -0.7567
A4DAB288_4imk_B_C 4imk 100% -0.692 6.5 4.0 -0.3162 -0.7486
A4DAB288_7v5n_F_E 7v5n 100% -0.6761 6.5 4.0 -0.2723 -0.7296
A4DAB288_6bft_A_B 6bft 98% -0.713 6.5 4.0 -0.3946 -0.754
A4DAB288_1cz8_Y_X 1cz8 97% -0.6636 6.5 4.0 -0.0974 -0.7379
A4DAB288_4imk_A_D 4imk 100% -0.6904 6.5 4.0 -0.3543 -0.7415
A4DAB288_4iml_A_B 4iml 100% -0.7027 6.5 4.0 -0.3703 -0.7525
A4DAB288_7v5n_B_A 7v5n 100% -0.6788 6.5 4.0 -0.3101 -0.7267
A4DAB288_4iml_H_L 4iml 100% -0.7462 7.0 4.0 -0.397 -0.7986
A4DAB288_1bj1_K_J 1bj1 100% -0.6424 6.5 4.0 -0.171 -0.7042
A4DAB288_1cz8_H_L 1cz8 97% -0.6603 6.5 4.0 -0.0949 -0.7345